Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-ΚB-dependent mechanism

International Journal of Molecular Medicine

Volumn 32, Issue 3, 2013, Pages 717-722

  Yu, Liangzhu ^a,b   She, Tonghui ^a,b   Li, Mincai ^a,b   Shi, Chunrong ^b   Han, Lu ^b   Cheng, Menglin ^a  

^a Hubei Province Key Laboratory on Cardiovascular Cerebrovascular and Metabolic Disorders   (China)

^b HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cardiomyocyte; Hypertrophy; Nuclear factor B; Tetramethylpyrazine; Tumor necrosis factor

Indexed keywords

ANGIOTENSIN II; DNA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUCINE; MYOSIN HEAVY CHAIN BETA; PYRROLIDINE DITHIOCARBAMATE; TETRAMETHYLPYRAZINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; HEART MUSCLE CELL; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; UPREGULATION;

ANGIOTENSIN II; ANIMALS; CELL ENLARGEMENT; CELLS, CULTURED; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HYPERTROPHY; MYOCYTES, CARDIAC; NF-KAPPA B; PROTEIN BIOSYNTHESIS; PROTEIN TRANSPORT; PYRAZINES; RATS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880406015     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1436     Document Type: Article

References (29)

1. Levy D, Garrison RJ, Savage DD, Kannel WB and Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566, 1990.
2. Sadoshima J and Izumo S: Molecular characterization of angiotensin II - induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73: 413-423, 1993.
3. Lee KH, Jang Y and Chung JH: Heat shock protein 90 regulates IkappaB kinase complex and NF-kappaB activation in angiotensin II-induced cardiac cell hypertrophy. Exp Mol Med 42: 703-711, 2010.
4. Gupta S, Young D, Maitra RK, et al: Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol 375: 637-649, 2008.
5. Chen KJ and Chen K: Ischemic stroke treated with Ligusticum chuanxiong. Chin Med J (Engl) 105: 870-873, 1992.
6. Sutter MC and Wang YX: Recent cardiovascular drugs from Chinese medicinal plants. Cardiovasc Res 27: 1891-1901, 1993.
7. Feng J, Wu G and Tang S: The effects of tetramethylpyrazine on the incidence of arrhythmias and the release of PGI2 and TXA2 in the ischemic rat heart. Planta Med 65: 268-270, 1999.
8. Fan L, Wang K, Shi Z, Die J, Wang C and Dang X: Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury. J Vasc Surg 54: 192-200, 2011.
9. Liu CF, Lin CH, Chen CF, Huang TC and Lin SC: Antioxidative effects of tetramethylpyrazine on acute ethanol-induced lipid peroxidation. Am J Chin Med 33: 981-988, 2005.
10. 2+/calmodulin-dependent protein kinase II and calcineurin in TNF-alpha-induced myocardial hypertrophy. Braz J Med Biol Res 45: 1045-1051, 2012.
11. Hu Y, Li T, Wang Y, et al: Tollip attenuated the hypertrophic response of cardiomyocytes induced by IL-1beta. Front Biosci 14: 2747-2756, 2009.
12. Yokoyama T, Sekiguchi K, Tanaka T, et al: Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. Am J Physiol 276: H1968-H1976, 1999.
13. Huang Y, Zhang H, Shao Z, et al: Suppression of endothelin-1-induced cardiac myocyte hypertrophy by PPAR agonists: role of diacylglycerol kinase zeta. Cardiovasc Res 90: 267-275, 2011.
14. Feng J, Liu R, Wu G and Tang S: Effects of tetramethylpyrazine on the release of PGI2 and TXA2 in the hypoxic isolated rat heart. Mol Cell Biochem 167: 153-158, 1997.
15. Zou LY, Hao XM, Zhang GQ, Zhang M, Guo JH and Liu TF: Effect of tetramethyl pyrazine on L-type calcium channel in rat ventricular myocytes. Can J Physiol Pharmacol 79: 621-626, 2001.
16. Gao S, Chen ZW, Zheng H and Chen XL: Ligustrazine attenuates acute myocardium injury after thermal trauma. Burns 33: 321-327, 2007.
17. Zhao HP, Lu D, Zhang W, et al: Protective action of tetramethylpyrazine phosphate against dilated cardiomyopathy in cTnT(R141W) transgenic mice. Acta Pharmacol Sin 31: 281-288, 2010.
18. Rajapurohitam V, Kilic A, Javadov S and Karmazyn M: Role of NF-kappaB and p38 MAPK activation in mediating angiotensin II and endothelin-1-induced stimulation in leptin production and cardiomyocyte hypertrophy. Mol Cell Biochem 366: 287-297, 2012.
19. Liu Q, Chen Y, Auger-Messier M and Molkentin JD: Interaction between NFkappaB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ Res 110: 1077-1086, 2012.
20. Valente AJ, Clark RA, Siddesha JM, Siebenlist U and Chandrasekar B: CIKS (Act1 or TRAF3IP2) mediates angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy. J Mol Cell Cardiol 53: 113-124, 2012.
21. Freund C, Schmidt-Ullrich R, Baurand A, et al: Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo. Circulation 111: 2319-2325, 2005.
22. Wang D and Baldwin AS Jr: Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J Biol Chem 273: 29411-29416, 1998.
23. Baldwin AS Jr: The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683, 1996.
24. Kawano S, Kubota T, Monden Y, et al: Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II. Cardiovasc Res 67: 689-698, 2005.
25. Sun M, Chen M, Dawood F, et al: Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 115: 1398-1407, 2007.
26. Janczewski AM, Kadokami T, Lemster B, Frye CS, McTiernan CF and Feldman AM: Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha. Am J Physiol Heart Circ Physiol 284: H960-H969, 2003.
27. Nakamura K, Fushimi K, Kouchi H, et al: Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 98: 794-799, 1998.
28. Ock S, Ahn J, Lee SH, et al: Receptor activator of nuclear factor-kappaB ligand is a novel inducer of myocardial inflammation. Cardiovasc Res 94: 105-114, 2012.
29. Sriramula S, Haque M, Majid DS and Francis J: Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 51: 1345-1351, 2008.